A12CB01 zinc sulfate
ALIMENTARY TRACT AND METABOLISM ›MINERAL SUPPLEMENTS ›OTHER MINERAL SUPPLEMENTS ›Zinc
健保收載品項 TFDA 在效許可證 3 FDA 已核准
台灣藥品與外觀
健保收載品名："人人"鋅錠15公絲、"信東" 硫酸鋅注射液５．９４毫克／毫升、"壽元"鋅咀嚼錠１５公絲
資料來源：食藥署「西藥許可證」＋「藥品 ATC 碼」＋「藥品外觀」＋「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 用於加入相容性之靜脈輸液或全靜脈營養(TPN)溶液中、治療鋅缺乏症。
- 補充鋅元素、醫治鋅元素缺乏症。
- 鋅缺乏症、眼部不適之用藥。
美國 FDA 適應症（英文原文對照）
The MEB PainGuard Patch is designed to provide effective pain relief and treat various types of pain, providing fast-acting and long-lasting relief from pain, helping to alleviate discomfort caused by muscle pain, nerve pain, and other common types of pain. This innovative patch targets and treats the underlying inflammation that causes pain to help eliminate the root cause of pain, leading to more effective and sustainable pain relief. The Gluco Vitality Patch assists individuals with diabetes in stabilizing their blood sugar levels while promoting vascular health to provide a comprehensive approach to diabetes care. By promoting vascular health, the GlucoVitaPatch aims to improve circulation and support the prevention and treatment of vascular diseases commonly associated with diabetes.
資料來源：食藥署西藥許可證適應症（中文）、openFDA US SPL（英文，僅供對照）。
健保給付規定
查無健保特殊給付規定條款；本藥品依一般健保藥品支付規定給付。
實證補充
本藥品尚無實證補充整理（未來新增 Review／指引知識時補列）。
台灣藥品與適應症：食藥署西藥許可證＋ATC＋外觀＋仿單開放資料 · FDA：openFDA US SPL · 健保給付：健保署「全民健康保險藥品給付規定」（更新日 2026-06-09）· 實證補充：人工彙整。 本頁為資訊整理，實際給付與適應症以主管機關公告為準。